scholarly journals β-fibrinogen gene G/A-455 polymorphism in relation to fibrinogen concentrations and ischaemic heart disease in Chinese patients with Type II diabetes

Diabetologia ◽  
1999 ◽  
Vol 42 (10) ◽  
pp. 1250-1253 ◽  
Author(s):  
K. S. L. Lam ◽  
O. C. K. Ma ◽  
N. M. S. Wat ◽  
L. C. Chan ◽  
E. D. Janus
Keyword(s):  
Heart Disease ◽  
Ischaemic Heart Disease ◽  
Type Ii Diabetes ◽  
Chinese Patients ◽  
Type Ii

Metformin-Associated Lactic Acidosis in Chinese Patients with Type II Diabetes

Pharmacology ◽  
2011 ◽  
Vol 88 (5-6) ◽  
pp. 260-265 ◽  
Author(s):  
Chun Wing Yeung ◽  
Ho Yin Chung ◽  
Bonnie Mei Wah Fong ◽  
Nga Wing Tsai ◽  
Wai Ming Chan ◽  
...  
Keyword(s):  
Lactic Acidosis ◽  
Type Ii Diabetes ◽  
Chinese Patients ◽  
Type Ii

Macroangiopathy in type II diabetes

1983 ◽  
Vol 104 (4_Suppl) ◽  
pp. S75-S78
Author(s):  
Antti Aro
Keyword(s):  
Coronary Heart Disease ◽  
Heart Disease ◽  
Vascular Disease ◽  
Peripheral Vascular Disease ◽  
Type Ii Diabetes ◽  
Clinical Manifestations ◽  
Diabetic Patients ◽  
Type Ii ◽  
Peripheral Vascular ◽  
Middle Aged

ABSTRACT. Macroangiopathy is the most important cause of mortality and morbidity in type II diabetes. The atherosclerotic process in diabetes is similar to that found in non-diabetic subjects, but the laesions are more extensive and the clinical manifestations are more common in diabetic subjects than in the non-diabetic population. In diabetic patients from different populations, the prevalence of macroangiopathy is variable, and the relative frequency follows the pattern found in the respective non-diabetic populations. The relative risk of large vessel disease is in most populations higher for female than for male diabetics. Coronary heart disease is the most important manifestation of macroangiopathy while cerebrovascular disease and peripheral vascular disease are less frequent, although all these manifestations occur at increased frequency among middle-aged diabetic subjects. The incidence of peripheral vascular disease seems to increase with increasing duration of diabetes in middle-aged subjects, whereas coronary heart disease is particularly frequent in type II diabetes already at the time of the diagnosis. Key words: atherosclerosis, complications, diabetes mellitus, macroangiopathy, mortality.

Adherence to clinical guidelines in the prevention of coronary heart disease in type II diabetes mellitus

2007 ◽  
Vol 30 (1) ◽  
pp. 120-127 ◽  
Author(s):  
Majidreza Kamyar ◽  
B. Julienne Johnson ◽  
John J. McAnaw ◽  
Rosa Lemmens-Gruber ◽  
Steve A. Hudson
Keyword(s):  
Diabetes Mellitus ◽  
Coronary Heart Disease ◽  
Heart Disease ◽  
Clinical Guidelines ◽  
Type Ii Diabetes ◽  
Type Ii Diabetes Mellitus ◽  
Type Ii

Plasma C3d Levels and Ischemic Heart Disease in Type II Diabetes

Diabetes Care ◽  
1993 ◽  
Vol 16 (2) ◽  
pp. 445-449 ◽  
Author(s):  
A. Figueredo ◽  
J. L. Ibarra ◽  
J. Bagazgoitia ◽  
A. Rodriguez ◽  
A. M. Molino ◽  
...  
Keyword(s):  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Type Ii Diabetes ◽  
Ischemic Heart ◽  
Type Ii

scholarly journals Coronary Heart Disease in Postmenopausal Women with Type II Diabetes Mellitus and the Impact of Estrogen Replacement Therapy: A Narrative Review

2014 ◽  
Vol 2014 ◽  
pp. 1-8 ◽  
Author(s):  
Marouane Boukhris ◽  
Salvatore Davide Tomasello ◽  
Francesco Marzà ◽  
Sonia Bregante ◽  
Francesca Romana Pluchinotta ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Coronary Heart Disease ◽  
Heart Disease ◽  
Cardiovascular Risk ◽  
Type Ii Diabetes ◽  
Estrogen Replacement Therapy ◽  
Type Ii Diabetes Mellitus ◽  
Type Ii ◽  
Estrogen Replacement ◽  
The Impact

Coronary heart disease is the main cause of death in postmenopausal women (PMW); moreover its mortality exceeds those for breast cancer in women at all ages. Type II diabetes mellitus is a major cardiovascular risk factor and there is some evidence that the risk conferred by diabetes is greater in women than in men. It was established that the deficiency of endogenous estrogens promotes the atherosclerosis process. However, the impact of estrogen replacement therapy (ERT) on cardiovascular prevention remains controversial. Some authors strongly recommend it, whereas others revealed a concerning trend toward harm. This review tries to underlines the different components of cardiovascular risk in diabetic PMW and to define the place of ERT.

scholarly journals Laparoscopic Roux-en-Y Gastric Bypass for the Treatment of Type II Diabetes Mellitus in Chinese Patients with Body Mass Index of 25–35

2011 ◽  
Vol 21 (9) ◽  
pp. 1344-1349 ◽  
Author(s):  
Chih-Kun Huang ◽  
Asim Shabbir ◽  
Chi-Hsien Lo ◽  
Chi-Ming Tai ◽  
Yaw-Sen Chen ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Body Mass Index ◽  
Gastric Bypass ◽  
Body Mass ◽  
Type Ii Diabetes ◽  
Type Ii Diabetes Mellitus ◽  
Chinese Patients ◽  
Type Ii
Sign in / Sign up

Export Citation Format

Share Document